1	Estreptomicina	estreptomicina	NCFS000	C0038425	sustancia	0-14	780_ANS_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
2	Cefuroxima	cefuroxima	NC00SC0	C0007562	producto#sustancia	0-10	780_ANS_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
3	Colistina	colistina	NC00SC0	C0009316	producto#sustancia	0-9	780_ANS_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
4	Quinupristina-dalfopristina	quinupristina-dalfopristina	AQ0FS00	-	-	0-27	780_ANS_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
5	Ampicilina	ampicilina	NCFS000	C0002680	sustancia	0-10	780_ANS_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
6	Metformina	metformina	NC00SC0	C0025598	producto#sustancia	0-10	780_ANS_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
7	(	(	Fpa	-	-	11-12	780_ANS_clinical_caseMIR	SENT1	-	-
8	biguanida	biguanida	NC00SC0	C0005382	producto#sustancia	12-21	780_ANS_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
9	)	)	Fpt	-	-	21-22	780_ANS_clinical_caseMIR	SENT1	-	-
10	.	.	Fp	-	-	22-23	780_ANS_clinical_caseMIR	SENT1	-	-

1	Pioglitazona	pioglitazona	NC00SC0	C0071097	producto#sustancia	0-12	780_ANS_clinical_caseMIR	SENT2	B-Grp_Medicamento	-
2	(	(	Fpa	-	-	13-14	780_ANS_clinical_caseMIR	SENT2	-	-
3	tiazolidindiona	tiazolidindiona	VMIP3S0	-	-	14-29	780_ANS_clinical_caseMIR	SENT2	B-Grp_Medicamento	-
4	)	)	Fpt	-	-	29-30	780_ANS_clinical_caseMIR	SENT2	-	-
5	.	.	Fp	-	-	30-31	780_ANS_clinical_caseMIR	SENT2	-	-

1	Canagliflozina	canagliflozina	NCFS000	-	-	0-14	780_ANS_clinical_caseMIR	SENT3	B-Grp_Medicamento	-
2	(	(	Fpa	-	-	15-16	780_ANS_clinical_caseMIR	SENT3	-	-
3	inhibidor	inhibidor	NCMS000	-	-	16-25	780_ANS_clinical_caseMIR	SENT3	B-Grp_Medicamento	-
4	del	del	SP+DA	-	-	26-29	780_ANS_clinical_caseMIR	SENT3	-	-
5	cotransportador	cotransportador	NCMS000	-	-	30-45	780_ANS_clinical_caseMIR	SENT3	-	-
6	2	2		-	-	46-47	780_ANS_clinical_caseMIR	SENT3	-	-
7	de	de	SPS00	C0332285	atributo	48-50	780_ANS_clinical_caseMIR	SENT3	-	-
8	sodioglucosa	sodioglucosa	NCFS000	-	-	51-63	780_ANS_clinical_caseMIR	SENT3	-	-
9	-	-	Fg	-	-	63-64	780_ANS_clinical_caseMIR	SENT3	-	-
10	iSGLT2	iSGLT2		-	-	65-71	780_ANS_clinical_caseMIR	SENT3	-	-
11	)	)	Fpt	-	-	71-72	780_ANS_clinical_caseMIR	SENT3	-	-
12	.	.	Fp	-	-	72-73	780_ANS_clinical_caseMIR	SENT3	-	-

1	Liraglutida	liraglutida	NC00SC0	C1456408	sustancia#producto	0-11	780_ANS_clinical_caseMIR	SENT4	B-Grp_Medicamento	-
2	(	(	Fpa	-	-	12-13	780_ANS_clinical_caseMIR	SENT4	-	-
3	agonista	agonista	NCCS000	-	-	13-21	780_ANS_clinical_caseMIR	SENT4	-	-
4	del	del	SP+DA	-	-	22-25	780_ANS_clinical_caseMIR	SENT4	-	-
5	receptor	receptor	NCMS000	C0597357	sustancia	26-34	780_ANS_clinical_caseMIR	SENT4	-	-
6	para	para	SPS00	C0521125	calificador	35-39	780_ANS_clinical_caseMIR	SENT4	-	-
7	GLP-1	GLP-1		-	-	40-45	780_ANS_clinical_caseMIR	SENT4	-	-
8	)	)	Fpt	-	-	45-46	780_ANS_clinical_caseMIR	SENT4	-	-
9	.	.	Fp	-	-	46-47	780_ANS_clinical_caseMIR	SENT4	-	-

